Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

The Clinical Significance of the Glomerular Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Renal Function of Caucasian Patients with Compound Heterozygosity for Hb S and β-Thalassemia

Ioannis Papassotiriou, Anastasia Bartzeliotou, Pagona Flevari, Maria Dimopoulou, Charalambos Kapogiannis, Vassiliki Kappou, Veroniki Komninaka, Konstantina Repa, Aimilia Mantzou, Alexandra Margeli, Eleni Pergantou, Christos Poziopoulos, Ersi Voskaridou

Blood (2022) 140 (Supplement 1): 8254–8255.

https://doi.org/10.1182/blood-2022-155859

Published: 2022

Journal Articles

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) As a Biomarker of Renal Outcomes in AL Amyloidosis

Efstathios Kastritis, MD, Ioannis Papassotiriou, PhD, Foteini Theodorakakou, MD, Alexandra Margeli, PhD, Anastasia Barzteliotou, PhD, Eleni Tsiligkeridou, Amalia Andreatou, Despina Fotiou, BMBS, MA, Magdalini Migkou, Nikolaos Kanellias, MD, Ioanna Dialoupi, MD, Ioannis Ntanasis-Stathopoulos, MD, Panagiotis Malandrakis, MD, Maria Gavriatopoulou, Evangelos Terpos, MD PhD, Meletios A Dimopoulos

Blood (2020) 136 (Supplement 1): 33.

https://doi.org/10.1182/blood-2020-136774

Published: 2020

Journal Articles

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Renal Biomarker with Potential Clinical Applications in Monoclonal Gammopathy of Renal Significance (MGRS)

Eftathios Kastritis, Ioannis Papassotiriou, PhD, Maria Roussou, MD, Maria Gavriatopoulou, MD, Mantzou Aimilia, PhD, Erasmia Psimenou, MD, Smaragdi Marinaki, Charikleia Gakiopoulou, MD, Alexandra Margeli, PhD, Nikolaos Kanellias, MD, Magdalini Migkou, MD, Despina Fotiou, BMBS, MA, Ioannis Ntanasis-Stathopoulos, MD, Gerasimos-Petros Papassotiriou, PhD, Aristea-Maria Papanota, MD, Evangelos Terpos, MD PhD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 3126.

https://doi.org/10.1182/blood-2019-125305

Published: 2019

Journal Articles

Serum Neutrophil Gelatinase-Associated Lipocalin Independently Predicts for Renal Response in Myeloma Patients with Severe Renal Impairment

Meletios A. Dimopoulos, MD, Maria Roussou, MD, Eftathios Kastritis, Alexandra Margeli, PhD, Evangelos Eleutherakis-Papaiakovou, MD, Ioannis Ntanasis-Stathopoulos, MD, Nikolaos Kanellias, MD, Gerasimos-Petros Papassotiriou, PhD, Despina Fotiou, MD, Magdalini Migkou, MD, Maria Gavriatopoulou, MD, Erasmia Psimenou, MD, Ioannis Papassotiriou, PhD, Evangelos Terpos, MD PhD

Blood (2019) 134 (Supplement_1): 1877.

https://doi.org/10.1182/blood-2019-123912

Published: 2019

Journal Articles

Distinct Biomarkers Reflect Pathophysiological Differences of Sickle Cell Disease Sub-Phenotypes: Viscosity-Vaso-Occlusion Vs. Hemolysis-Endothelial Dysfunction

Ioannis Papassotiriou, PhD, Christos Poziopoulos, MD, Katerina Larissi, MD, Alexandra Margeli, Marianna Politou, MD, Evangelos Terpos, MD, Ersi Voskaridou

Blood (2017) 130 (Supplement 1): 3520.

https://doi.org/10.1182/blood.V130.Suppl_1.3520.3520

Published: 2017

Journal Articles

The Growth Differentiation Factor-15 Levels Are Increased in Patients with Compound Heterozygous Sickle Cell and Beta-Thalassemia, Correlate with Hepcidin-25/Ferritin Molar Ratio and with Markers of Hemolysis, Endothelial Dysfunction and Angiogenesis

Ioannis Papassotiriou, PhD, Katerina Larrisi, MD, Alexandra Margeli, PhD, Dimitrios Christoulas, Maria Dimopoulou, MD, Vaughn Ostland, PhD, Christos Poziopoulos, Mark Westerman, PhD, Marianna Politou, MD, Ersi Voskaridou, MD, Evangelos Terpos, MD PhD

Blood (2016) 128 (22): 3646.

https://doi.org/10.1182/blood.V128.22.3646.3646

Published: 2016

Journal Articles

Assessment of Serum Bioactive Hepcidin-25, Soluble Transferrin Receptor and Their Ratio in Predialysis Patients: Correlation with the Response to Intravenous Ferric Carboxymaltose Administration

Athina Drakou, MD, Christos Poziopoulos, MD, Alexandra Margeli, PhD, Ioannis Papassotiriou, PhD, Demetrios Vlahakos, MD

Blood (2015) 126 (23): 949.

https://doi.org/10.1182/blood.V126.23.949.949

Published: 2015

Journal Articles

Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Thalassemia and Sickle Cell Disease: Correlation with Renal Injury

Ioannis Papassotiriou, PhD, Voskaridou Ersi, MD, Alexandra Margeli, PhD, Theresa Nwagha, MD, Athanassia Kotrotsou, MD, Dimitra Kyriakopoulou, MD, Christos Poziopoulos, MD, Antonios Kattamis, MD

Blood (2014) 124 (21): 4078.

https://doi.org/10.1182/blood.V124.21.4078.4078

Published: 2014

Journal Articles

Tubular Damage Is Present In Patients With MGUS and Asymptomatic Multiple Myeloma Even In The Absence Of Impaired Estimated Glomerular Filtration Rate; Alterations Of Neutrophil Gelatinase-Associated Lipocalin and Cystatin-C In Myeloma Patients Post IMiD- and Bortezomib-Based Regimens

Evangelos Terpos, Dimitrios Christoulas, Efstathios Kastritis, Gerasimos-Petros Papassotiriou, Filia Apostolakou, Alexandra Margeli, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Ioannis Papassotiriou, Meletios A. Dimopoulos, MD

Blood (2013) 122 (21): 3091.

https://doi.org/10.1182/blood.V122.21.3091.3091

Published: 2013

Journal Articles

Tubular Damage Is Ubiquitous in Newly-Diagnosed Patients with Multiple Myeloma: Comparison of Three Urinary and Two Serum Markers of Kidney Injury.

Meletios A Dimopoulos, MD, Dimitrios Christoulas, Efstathios Kastritis, Maria Gkotzamanidou, Alexandra Margeli, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Ioannis Papassotiriou, Evangelos Terpos

Blood (2012) 120 (21): 2919.

https://doi.org/10.1182/blood.V120.21.2919.2919

Published: 2012

Journal Articles

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin-C Are Sensitive Markers of Renal Injury in Patients with Multiple Myeloma,

Evangelos Terpos, Gerasimos-Petros Papassotiriou, Efstathios Kastritis, Maria Gkotzamanidou, Dimitrios Christoulas, Evangelos Eleutherakis-Papaiakovou, Alexandra Margeli, Magdalini Migkou, Maria Gavriatopoulou, Maria Roussou, Ioannis Papassotiriou, Meletios Athanasios Dimopoulos, MD

Blood (2011) 118 (21): 3918.

https://doi.org/10.1182/blood.V118.21.3918.3918

Published: 2011

Journal Articles

Fluctuation of Cystatin C Concentration during Deferasirox Treatment in Thalassemic Patients May Reflect Hemodynamic Changes

Ioannis Papassotiriou, PhD, Antonios Kattamis, MD, Eugenia Hantzi, BSc, Polyxeni Delaporta, MD, Athanassia Sergounioti, MD, Alexandra Margeli, PhD, Vassilios Ladis, MD

Blood (2008) 112 (11): 5419.

https://doi.org/10.1182/blood.V112.11.5419.5419

Published: 2008

Journal Articles

Increased Plasma Levels of NGAL and IL-18 Correlate with Reduced GFR Providing Two Novel Biomarkers for Kidney Injury Assessment: Evidence of Early Tubuloglomerular Defect in Patients with HbS/b-Thalassemia

Ioannis Papassotiriou, PhD, Alexandra Margeli, PhD, Eugenia Hantzi, BSc, Evangelos Terpos, MD, Ersi Voskaridou

Blood (2008) 112 (11): 4805.

https://doi.org/10.1182/blood.V112.11.4805.4805

Published: 2008

Journal Articles

Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Thalassemia Intermedia: Lack of Association with Erythropoiesis, Iron Metabolism, Renal Dysfunction and Inflammation.

Ioannis Papassotiriou, Alexandra Margeli, Antonios Drakatos, Sophia Delikou, Korina Kassiou, Christos Kattamis, Vassilios Ladis, Antonios Kattamis

Blood (2007) 110 (11): 3814.

https://doi.org/10.1182/blood.V110.11.3814.3814

Published: 2007

Journal Articles

Effect of Acute Inflammation Induced by Prolonged Exercise on Circulating Stem/Progenitor Cells That Mediate Tissue Repair.

Ioannis Papassotiriou, PhD, Antonia Spiropoulos, PhD, Maria Tsironi, MD, Katerina Skenderi, PhD, Alexandra Margeli, PhD, Stelios Graphakos, MD, Panayiotis Baltopoulos, MD, Evgenios Goussetis, MD

Blood (2007) 110 (11): 3902.

https://doi.org/10.1182/blood.V110.11.3902.3902

Published: 2007

Journal Articles

Assessment of Renal Function in Transfused b-Thalassemia Patients Based on Cystatin C Measurements and Equations.

Antonios Kattamis, Alexandra Margeli, Eugenia Hantzi, George Paleologos, Athanasia Sergounioti, Athanasia Lourida, Natalia Lazopoulou, Vassilios Ladis, Ioannis Papassotiriou

Blood (2007) 110 (11): 2769.

https://doi.org/10.1182/blood.V110.11.2769.2769

Published: 2007

Journal Articles

Circulating Levels of Adhesion Molecules and Markers of Endothelial Dysfunction in Acute Inflammation Induced by Prolonged Brisk Exercise: Rapid Endothelial Recovery and Potential Beneficial Effects.

Ioannis Papassotiriou, PhD, Anastasia Bartzeliotou, PhD, Alexandra Margeli, PhD, Maria Tsironi, MD, Katerina Skenderi, PhD, Chryssa Bacoula, MD, George Chrousos, MD

Blood (2006) 108 (11): 3921.

https://doi.org/10.1182/blood.V108.11.3921.3921

Published: 2006

Journal Articles

Long Term Treatment with Hydroxyurea Does Not Prevent Development of Renal Dysfunction and Osteodystrophy in Patients with Sickle Cell Disease.

Ersi Voskaridou, Evangelos Terpos, Alexandra Margeli, Eugenia Hantzi, Eleni Stoupa, Aphroditi Loutradi, Ioannis Papassotiriou, Dimitris Loukopoulos

Blood (2004) 104 (11): 1675.

https://doi.org/10.1182/blood.V104.11.1675.1675

Published: 2004

NARROW

The Clinical Significance of the Glomerular Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Renal Function of Caucasian Patients with Compound Heterozygosity for Hb S and β-Thalassemia

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) As a Biomarker of Renal Outcomes in AL Amyloidosis

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Renal Biomarker with Potential Clinical Applications in Monoclonal Gammopathy of Renal Significance (MGRS)

Serum Neutrophil Gelatinase-Associated Lipocalin Independently Predicts for Renal Response in Myeloma Patients with Severe Renal Impairment

Distinct Biomarkers Reflect Pathophysiological Differences of Sickle Cell Disease Sub-Phenotypes: Viscosity-Vaso-Occlusion Vs. Hemolysis-Endothelial Dysfunction

The Growth Differentiation Factor-15 Levels Are Increased in Patients with Compound Heterozygous Sickle Cell and Beta-Thalassemia, Correlate with Hepcidin-25/Ferritin Molar Ratio and with Markers of Hemolysis, Endothelial Dysfunction and Angiogenesis

Assessment of Serum Bioactive Hepcidin-25, Soluble Transferrin Receptor and Their Ratio in Predialysis Patients: Correlation with the Response to Intravenous Ferric Carboxymaltose Administration

Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Thalassemia and Sickle Cell Disease: Correlation with Renal Injury

Tubular Damage Is Present In Patients With MGUS and Asymptomatic Multiple Myeloma Even In The Absence Of Impaired Estimated Glomerular Filtration Rate; Alterations Of Neutrophil Gelatinase-Associated Lipocalin and Cystatin-C In Myeloma Patients Post IMiD- and Bortezomib-Based Regimens

Tubular Damage Is Ubiquitous in Newly-Diagnosed Patients with Multiple Myeloma: Comparison of Three Urinary and Two Serum Markers of Kidney Injury.

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin-C Are Sensitive Markers of Renal Injury in Patients with Multiple Myeloma,

Fluctuation of Cystatin C Concentration during Deferasirox Treatment in Thalassemic Patients May Reflect Hemodynamic Changes

Increased Plasma Levels of NGAL and IL-18 Correlate with Reduced GFR Providing Two Novel Biomarkers for Kidney Injury Assessment: Evidence of Early Tubuloglomerular Defect in Patients with HbS/b-Thalassemia

Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Thalassemia Intermedia: Lack of Association with Erythropoiesis, Iron Metabolism, Renal Dysfunction and Inflammation.

Effect of Acute Inflammation Induced by Prolonged Exercise on Circulating Stem/Progenitor Cells That Mediate Tissue Repair.

Assessment of Renal Function in Transfused b-Thalassemia Patients Based on Cystatin C Measurements and Equations.

Circulating Levels of Adhesion Molecules and Markers of Endothelial Dysfunction in Acute Inflammation Induced by Prolonged Brisk Exercise: Rapid Endothelial Recovery and Potential Beneficial Effects.

Long Term Treatment with Hydroxyurea Does Not Prevent Development of Renal Dysfunction and Osteodystrophy in Patients with Sickle Cell Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only